Stocks and Investing Stocks and Investing
Fri, January 8, 2021

Matthew O"Brien Maintained (ZBH) at Buy with Increased Target to $185 on, Jan 8th, 2021


Published on 2024-10-27 15:09:06 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $160 to $185 on, Jan 8th, 2021.

Matthew has made no other calls on ZBH in the last 4 months.

There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 1 agrees with Matthew"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;

Jason Wittes of "Northland Capital Markets" Initiated at Hold and Held Target at $150 on, Tuesday, October 20th, 2020

These are the ratings of the 7 analyists that currently disagree with Matthew;

Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $175 on, Monday, January 4th, 2021
Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $185 on, Friday, December 18th, 2020
Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $180 on, Wednesday, December 16th, 2020
David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $170 on, Tuesday, December 15th, 2020
Richard Newitter of "SVB Leerink" Maintained at Buy with Increased Target to $175 on, Monday, December 14th, 2020
Jeff Johnson of "Baird" Maintained at Buy and Held Target at $154 on, Monday, November 9th, 2020
Lawrence Keusch of "Raymond James" Maintained at Strong Buy with Increased Target to $170 on, Monday, October 12th, 2020

Contributing Sources